Pfizer-BioNTech Seek FDA Emergency Authorization for Children Ages 5 To 11 After Clinical Trials…
Developed in tandem by Pfizer and BioNTech, the two companies asked for approval from the Food and Drug Administration (FDA) to issue an emergency authorization for children aged 5 to 11 to be able to receive the COVID-19 vaccine.!-->…